![Kenneth Hallock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hallock
Direktör/Styrelseledamot på
GREENWICH LIFESCIENCES, INC.
Förmögenhet: 6 M $ per 2026-08-31
Profil
Kenneth Hallock is currently an Independent Director at Greenwich LifeSciences, Inc., a position held since 2019.
Mr. Hallock completed undergraduate studies at Princeton University and earned an MBA from Harvard Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-26 | 397 333 ( 2,71 % ) | 6 M $ | 2026-08-31 |
Aktiva positioner av Kenneth Hallock
| Företag | Position | Start |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Direktör/Styrelseledamot | 2019-09-01 |
Kenneth Hallocks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
6
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich LifeSciences, Inc.
 Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
